Intensive Blood Pressure Lowering and Risk of Diabetes: Friend or Foe?
Hypertension
.
2020 Feb;75(2):293-294.
doi: 10.1161/HYPERTENSIONAHA.119.14050.
Epub 2019 Dec 23.
Authors
Milad Nazarzadeh
1
2
3
,
Kazem Rahimi
1
2
4
Affiliations
1
From the Deep Medicine, Oxford Martin School (M.N., K.R.), University of Oxford, United Kingdom.
2
The George Institute for Global Health (M.N., K.R.), University of Oxford, United Kingdom.
3
The Collaboration Center of Meta-Analysis Research, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran (M.N.).
4
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, United Kingdom (K.R.).
PMID:
31865792
DOI:
10.1161/HYPERTENSIONAHA.119.14050
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antihypertensive Agents
Blood Pressure / drug effects
Blood Pressure Determination*
Diabetes Mellitus*
Substances
Antihypertensive Agents
Grants and funding
FS/19/36/34346/BHF_/British Heart Foundation/United Kingdom
DH_/Department of Health/United Kingdom